Clinical Trial Update: Treatment of Moyamoya Disease With iPSC-derived Exosomes [Phase 1]

View source ↗

Summary

This Phase 1 study is evaluating whether exosomes derived from induced pluripotent stem cells can treat Moyamoya Disease; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Moyamoya Disease

Drugs mentioned

• iPSC-derived exosome therapy (iPSC-derived exosomes)

Snippet

Sponsor: Huaqiu Zhang | Conditions: Moyamoya Disease | Phase 1 | Status: RECRUITING